1. CD318 is a target of chimeric antigen receptor T cells for the treatment of colorectal cancer

   • Ming Li
   • Shanglin Li
   • Peng Li

   Research 10 December 2022 Pages: 2409 - 2419

   

2. The non-invasive diagnosis of colorectal cancer via a SOX9-based gene panel

   • Vivian Weiwen Xue
   • Simon Siu Man Ng
   • Sze Chuen Cesar Wong

   Research 13 January 2023 Pages: 2421 - 2432

   

3. Serum CA724 has no diagnostic value for gastrointestinal tumors

   • Huiru Cao
   • Liuming Zhu
   • Xiaoping Niu

   Research Open access 15 March 2023 Pages: 2433 - 2442

   

4. Initial clinical and experimental analyses of ALDOA in gastric cancer, as a novel prognostic biomarker and potential therapeutic target

   • Liqiao Chen
   • Zizhen Wu
   • Jingyu Deng

   Research 24 November 2022 Pages: 2443 - 2456

   

5. SHF confers radioresistance in colorectal cancer by the regulation of mitochondrial DNA copy number

   • Zhenyu Zhu
   • Meihua Gong
   • Yanhan Jia

   Research 17 December 2022 Pages: 2457 - 2471

   

6. Research trends and hotspots of neoadjuvant therapy in pancreatic cancer: a bibliometric analysis based on the Web of Science Core Collection

   • Hong-yu Wu
   • Tao Liu
   • Jin-zheng Li

   Research 11 February 2023 Pages: 2473 - 2485

   

7. The modulation of iron metabolism affects the Rhabdomyosarcoma tumor growth in vitro and in vivo

   • Michela Asperti
   • Luca Cantamessa
   • Maura Poli

   Research Open access 10 February 2023 Pages: 2487 - 2502

   

8. Ex vivo expansion of natural killer cells for hematological cancer immunotherapy: a systematic review and meta-analysis

   • Hikmet Can Çubukçu
   • Pınar Yurdakul Mesutoğlu
   • Meral Beksaç

   Original Article 04 November 2022 Pages: 2503 - 2533

   

9. Effects of polybrene and retronectin as transduction enhancers on the development and phenotypic characteristics of VHH-based CD19-redirected CAR T cells: a comparative investigation

   • Fatemeh Nasiri
   • Samad Muhammadnejad
   • Fatemeh Rahbarizadeh

   Original Article 25 November 2022 Pages: 2535 - 2549

   

10. Phenotypic and functional characterisation of locally produced natural killer cells ex vivo expanded with the K562-41BBL-mbIL21 cell line

    • Tatsiana V. Shman
    • Katsiaryna P. Vashkevich
    • Olga V. Aleinikova

    Research 17 December 2022 Pages: 2551 - 2560

    

11. The efficiency of human umbilical cord mesenchymal stem cells as a salvage treatment for steroid-refractory acute graft-versus-host disease

    • Yihan Ding
    • Chang Liu
    • Depei Wu

    Research 04 January 2023 Pages: 2561 - 2570

    

12. Treatment of in vitro generated Langerhans cells with JAK-STAT inhibitor reduces their inflammatory potential

    • Sterkens Ann
    • Janssens Ibo
    • Cools Nathalie

    Original Article 25 October 2022 Pages: 2571 - 2582

    

13. A prognostic model incorporating inflammatory cells and cytokines for newly diagnosed multiple myeloma patients

    • Liang Ren
    • Jiadai Xu
    • Peng Liu

    Research 13 January 2023 Pages: 2583 - 2591

    

14. Low Barthel index score is a poor prognostic factor for newly diagnosed multiple myeloma patients

    • Chuanying Geng
    • Guangzhong Yang
    • Wenming Chen

    Research 26 January 2023 Pages: 2593 - 2600

    

15. Ferroptosis-related STEAP3 acts as predictor and regulator in diffuse large B cell lymphoma through immune infiltration

    • Xiaomin Chen
    • Shunfeng Hu
    • Xin Wang

    Research 22 January 2023 Pages: 2601 - 2617

    

16. Prolonged use of eltrombopag in patients with severe aplastic anemia in the real world

    • Ruixin Li
    • Ningling Wang
    • Jianyong Li

    Research 16 January 2023 Pages: 2619 - 2627

    

17. High WT1 expression predicted induction chemotherapy failure in acute myeloid leukemia patients with non-favorable cytogenetic risk

    • Nan Xu
    • Wen-Min Chen
    • Ya-Zhen Qin

    Research 13 January 2023 Pages: 2629 - 2638

    

18. DNA methylation-based subtypes of acute myeloid leukemia with distinct prognosis and clinical features

    • Jimo Jian
    • Chenglu Yuan
    • Fei Lu

    Research Open access 16 January 2023 Pages: 2639 - 2649

    

19. Prognostic value and therapeutic targeting of XPO1 in chronic lymphocytic leukemia

    • Zhangdi Xu
    • Bihui Pan
    • Wei Xu

    Research 04 February 2023 Pages: 2651 - 2662

    

20. Utility of public knowledge bases for the interpretation of comprehensive tumor molecular profiling results

    • Alexandra Lebedeva
    • Grigory Timokhin
    • Maxim Ivanov

    Research 08 February 2023 Pages: 2663 - 2674

    

21. Identification of FAT4 as a positive prognostic biomarker in DLBCL by comprehensive genomic analysis

    • Liyang Lv
    • Xiaolong Qi
    • Yan Li

    Research Open access 22 February 2023 Pages: 2675 - 2685

    

22. STAT1 overexpression triggers aplastic anemia: a pilot study unravelling novel pathogenetic insights in bone marrow failure

    • Antonio Giovanni Solimando
    • Vanessa Desantis
    • Angelo Vacca

    Research Open access 24 February 2023 Pages: 2687 - 2694

    

23. Sub-lethal doses of chemotherapeutic agents induce senescence in T cells and upregulation of PD-1 expression

    • Tetsuhiro Kasamatsu
    • Maaya Awata-Shiraiwa
    • Takayuki Saitoh

    Research 13 March 2023 Pages: 2695 - 2703

    

24. Efficacy of epigenetic agents for older patients with acute myeloid leukemia and myelodysplastic syndrome in randomized controlled trials: a systematic review and network meta-analysis

    • SuA Oh
    • EunYoung Kim

    Research 25 March 2023 Pages: 2705 - 2714

    

25. Real-world clinical outcomes of treatment with molnupiravir for patients with mild-to-moderate coronavirus disease 2019 during the Omicron variant pandemic

    • Yasuhito Suzuki
    • Yoko Shibata
    • Ken Iseki

    Original Article Open access 05 December 2022 Pages: 2715 - 2723

    

26. Multicenter epidemiological investigation and genetic characterization of respiratory syncytial virus and metapneumovirus infections in the pre-pandemic 2018–2019 season in northern and central Italy

    • Alessandra Pierangeli
    • Antonio Piralla
    • Fausto Baldanti

    Research 15 December 2022 Pages: 2725 - 2737

    

27. Outpatient anti-spike monoclonal antibody administration is associated with decreased morbidity and mortality among patients with cancer and COVID-19

    • Panos Arvanitis
    • Alexis Hope Lerner
    • Dimitrios Farmakiotis

    Research 13 February 2023 Pages: 2739 - 2748

    

28. Changing patterns and clinical outcomes of hospitalized patients with COVID-19 severe pneumonia treated with remdesivir according to vaccination status: results from a real-world retrospective study

    • Daniele Mengato
    • Maria Mazzitelli
    • Anna Maria Cattelan

    Research Open access 24 March 2023 Pages: 2749 - 2756

29. Correction to: Changing patterns and clinical outcomes of hospitalized patients with COVID‑19 severe pneumonia treated with remdesivir according to vaccination status: results from a real‑world retrospective study

    • Daniele Mengato
    • Maria Mazzitelli
    • Anna Maria Cattelan

    Correction Open access 08 June 2023 Pages: 2757 - 2757

30. Bibliometric analysis of the 100 most-cited papers about the role of gut microbiota in irritable bowel syndrome from 2000 to 2021

    • Changshan Wan
    • Xiangxu Kong
    • Bangmao Wang

    Research 15 December 2022 Pages: 2759 - 2772

    

31. The effects of probiotics on gastrointestinal symptoms and microbiota in patients with celiac disease: a systematic review and meta-analysis on clinical trials

    • Mohammadhossein Mozafarybazargany
    • Mohammadian Khonsari
    • Mostafa Qorbani

    Research 07 January 2023 Pages: 2773 - 2788

    

32. Relapse rates after withdrawal versus maintaining biologic therapy in IBD patients with prolonged remission

    • Annemay M. H. Stoker
    • Leslie Logghe
    • Lennard P. L. Gilissen

    Research 12 January 2023 Pages: 2789 - 2797

    

33. Effects of vonoprazan and proton pump inhibitors on the efficacy of bevacizumab: a multicentre retrospective study

    • Kenta Yagi
    • Akinori Maruo
    • Keisuke Ishizawa

    Research 04 February 2023 Pages: 2799 - 2804

    

34. Inflammation in the peripheral blood system of Crohn's Disease

    • Dan Li
    • Wenyong Gu
    • Yang Li

    Research 26 February 2023 Pages: 2805 - 2812

    

35. Autoimmune diseases and gut microbiota: a bibliometric and visual analysis from 2004 to 2022

    • Youao Zhang
    • Yongzheng Peng
    • Xu Xia

    Research Open access 01 March 2023 Pages: 2813 - 2827

    

36. Study of the immune response in celiac patients with selective IgA deficiency who start a gluten-free diet

    • Lola Giner-Pérez
    • Ester Donat
    • María Roca

    Research 13 March 2023 Pages: 2829 - 2838

    

37. miR-146a-3p as a potential novel therapeutic by targeting MBD2 to mediate Th17 differentiation in Th17 predominant neutrophilic severe asthma

    • Wentao Duan
    • Jin Huang
    • Xudong Xiang

    Research Open access 24 March 2023 Pages: 2839 - 2854

    

38. Association of Behçet’s disease with the risk of metabolic syndrome and its components: a systematic review and meta-analysis

    • Tingqiao Chen
    • Xinyi Shao
    • Jin Chen

    Research Open access 20 March 2023 Pages: 2855 - 2866

    

39. Small extracellular vesicles have distinct CD81 and CD9 tetraspanin expression profiles in plasma from rheumatoid arthritis patients

    • Anne Rydland
    • Fatima Heinicke
    • Benedicte A. Lie

    Research Open access 24 February 2023 Pages: 2867 - 2875

    

40. T lymphocyte subsets and immunoglobulin and complement levels are associated with the infection status of patients with antineutrophil cytoplasmic antibody-associated vasculitis

    • Rui Liu
    • Mengdi Li
    • Shengyun Liu

    Research 19 February 2023 Pages: 2877 - 2884

    

41. Thyroid autoimmunity following alemtuzumab treatment in multiple sclerosis patients: a prospective study

    • Paraskevi Kazakou
    • Dimitrios Tzanetakos
    • Evangelia Zapanti

    Research Open access 15 January 2023 Pages: 2885 - 2894

    

42. Expert consensus on the management of chronic lymphocytic leukaemia in Asia

    • Eric Tse
    • Yok Lam Kwong
    • Nadia Ayu Mulansari

    Correspondence Open access 16 February 2023 Pages: 2895 - 2907

    

43. Modulation of IRAK enzymes as a therapeutic strategy against SARS-CoV-2 induced cytokine storm

    • Ismail Sami Mahmoud
    • Yazun Bashir Jarrar
    • Febrimarsa

    Correspondence 15 April 2023 Pages: 2909 - 2923

    

44. Unique immune and inflammatory cytokine profiles may define long COVID syndrome

    • Lao-Tzu Allan-Blitz
    • Omid Akbari
    • Jeffrey D. Klausner

    Correspondence Open access 16 April 2023 Pages: 2925 - 2930